The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer

Table 2 Variables influencing actuarial rates of bRFS, RFS, MFS, OS

Characteristic	5-y bRFS	p	5-y RFS	p	5-y MFS	p	5-y OS	p
*Treatment scheme*		0.005		0.002		0.302		0.596
EBRT-BT	67		95		95		85
EBRT	81		99		94		85
*Age-median*		0.452		0.421		0.948		0.029
<66	70		95		95		90
≥66	80		98		94		82
*Risk group*		0.041		0.894		0.003		0.369
LR	83		97		98		85
IR	81		98		100		88
HR	65		96		88		84
*Total duration of ADT [months]*		0.089		0.748		0.555		0.156
<9.2	72		100		93		83
≥9.2	78		96		95		86

ISSN: 1748-717X